drugset / Trial / NCT00657228

Intravenous Heparin as an Adjunct for the Treatment of Anaphylactic Reactions in an Emergency Department

NCT00657228

RandomizedParallel-groupDouble-blindTreatment

Summary

To determine if intravenous unfractionated heparin (with standard therapy) for treatment of anaphylaxis results in faster time to recovery.

Timeline

Start
2009-12
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Heparin Other / unclassified 80 iu/kg Intravenous

Indications